Professor Seib is a NHMRC Leadership Fellow, Principal Research Leader, and the Associate Director (Research) at the Institute for Biomedicine and Glycomics, Griffith University. Prof Seib’s expertise is in the field of molecular microbiology and vaccinology, with a focus on understanding virulence mechanisms and vaccine development for human mucosal pathogens including Neisseria gonorrhoeae and Neisseria meningitidis.
Prof Seib worked for several years at Novartis Vaccines (Siena Italy) as a Postdoctoral Researcher and Project Leader, and was part of the team that developed the meningococcal serogroup B vaccine, 4CMenB. Prof Seib established her own research laboratory in Australia in 2013 with the aim to develop novel treatment and prevention options for N. gonorrhoeae. Her work includes the discovery, pre-clinical characterisation and clinical evaluation of gonococcal vaccine candidates, as well as the use of mathematical modelling to assess the potential impact of different vaccines and vaccine implementation strategies on gonococcal prevalence.